Buscar
Resmed Inc
RMDAñadir a la lista de seguimiento
191.890USD
0.0000.00%
Cierre 07-23 16:00（ET）Cotizaciones retrasadas 15 min
27.83BCap. mercado
18.43P/E TTM
Más Datos de Resmed Inc Compañía
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Información de Resmed Inc
Símbolo de cotizaciónRMD
Nombre de la empresaResmed Inc
Fecha de salida a bolsaJun 01, 1995
Director ejecutivoFarrell (Michael J)
Número de empleados10600
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 01
Dirección9001 Spectrum Center Blvd
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal92123
Teléfono18587462400
Sitio Webhttps://www.resmed.com/
Símbolo de cotizaciónRMD
Fecha de salida a bolsaJun 01, 1995
Director ejecutivoFarrell (Michael J)
Ejecutivos de Resmed Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.33%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+5.70%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+9.46%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+10.12%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+17.88%
Dr. Peter C. Farrell, Ph.D.
Dr. Peter C. Farrell, Ph.D.
Founder and Chairman Emeritus
Founder and Chairman Emeritus
--
--
Mr. Brett A. Sandercock
Mr. Brett A. Sandercock
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jan De Witte
Mr. Jan De Witte
Independent Director
Independent Director
--
--
Mr. Justin M. W. Leong
Mr. Justin M. W. Leong
Chief Product Officer
Chief Product Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.33%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+5.70%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+9.46%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+10.12%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+17.88%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Resmed Inc?
Los cinco principales accionistas de Resmed Inc son: Mr. Michael J. (Mick) Farrell
¿Cuántas instituciones poseen acciones de Resmed Inc (RMD)?
A fecha de 2026Q1, 1873 instituciones poseen acciones de Resmed Inc, con un valor de mercado combinado de aproximadamente 100.10M, lo que representa el 69.00% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1407565.00.
¿Cuál es la mayor fuente de ganancias de Resmed Inc?
El 2026Q1, el segmento empresarial Devices generó la ganancia más alta para Resmed Inc, ascendiendo a 726.21M y representando el 51.04% de la ganancia total.